Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Chabot

Showing results (111-120 of 121) with videos related to

Pageof 13
Sort By:
Theranostics|April 16, 2020
Noninvasive Young's modulus visualization of fibrosis progression and delineation of pancreatic ductal adenocarcinoma (PDAC) tumors using Harmonic Motion Elastography (HME) <i>in vivo</i>Alireza Nabavizadeh, Thomas Payen, Alina C Iuga, et al.
Cancer Chemotherapy and Pharmacology|February 2, 2013
Capecitabine and temozolomide (CAPTEM) for metastatic, well-differentiated neuroendocrine cancers: The Pancreas Center at Columbia University experienceRobert L Fine, Anthony P Gulati, Benjamin A Krantz, et al.
Surgical Endoscopy|June 2, 2026
EUS-guided drainage of symptomatic postoperative fluid collections: a retrospective cohort study evaluating timing of intervention and clinical outcomesMuhammad H Raza, Jonathan R Tiao, Catherine K Wang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 14, 2019
Harmonic Motion Imaging of Pancreatic Tumor Stiffness Indicates Disease State and Treatment ResponseThomas Payen, Paul E Oberstein, Niloufar Saharkhiz, et al.
Medicine|September 1, 2017
Comparison of the diagnostic accuracy of three current guidelines for the evaluation of asymptomatic pancreatic cystic neoplasmsMing-Ming Xu, Shi Yin, Ali A Siddiqui, et al.
Gastroenterology|December 17, 2020
Lead-Time Trajectory of CA19-9 as an Anchor Marker for Pancreatic Cancer Early DetectionJohannes F Fahrmann, C Max Schmidt, Xiangying Mao, et al.
The British Journal of Surgery|August 24, 2019
Validation of a nomogram to predict the risk of cancer in patients with intraductal papillary mucinous neoplasm and main duct dilatation of 10 mm or lessW Jung, T Park, Y Kim, et al.
Cell Reports. Medicine|September 20, 2023
A blood-based metabolomic signature predictive of risk for pancreatic cancerEhsan Irajizad, Ana Kenney, Tiffany Tang, et al.
Gut|December 20, 2023
Protein biomarkers and alternatively methylated cell-free DNA detect early stage pancreatic cancerRoni Ben-Ami, Qiao-Li Wang, Jinming Zhang, et al.
Biorxiv : the Preprint Server for Biology|December 18, 2023
Tumor-selective effects of active RAS inhibition in pancreatic ductal adenocarcinomaUrszula N Wasko, Jingjing Jiang, Alvaro Curiel-Garcia, et al.
Pageof 13

Showing results (111-120 of 121) with videos related to

Sort By:
Pageof 13
Theranostics|April 16, 2020
Noninvasive Young's modulus visualization of fibrosis progression and delineation of pancreatic ductal adenocarcinoma (PDAC) tumors using Harmonic Motion Elastography (HME) <i>in vivo</i>Alireza Nabavizadeh, Thomas Payen, Alina C Iuga, et al.
Cancer Chemotherapy and Pharmacology|February 2, 2013
Capecitabine and temozolomide (CAPTEM) for metastatic, well-differentiated neuroendocrine cancers: The Pancreas Center at Columbia University experienceRobert L Fine, Anthony P Gulati, Benjamin A Krantz, et al.
Surgical Endoscopy|June 2, 2026
EUS-guided drainage of symptomatic postoperative fluid collections: a retrospective cohort study evaluating timing of intervention and clinical outcomesMuhammad H Raza, Jonathan R Tiao, Catherine K Wang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 14, 2019
Harmonic Motion Imaging of Pancreatic Tumor Stiffness Indicates Disease State and Treatment ResponseThomas Payen, Paul E Oberstein, Niloufar Saharkhiz, et al.
Medicine|September 1, 2017
Comparison of the diagnostic accuracy of three current guidelines for the evaluation of asymptomatic pancreatic cystic neoplasmsMing-Ming Xu, Shi Yin, Ali A Siddiqui, et al.
Gastroenterology|December 17, 2020
Lead-Time Trajectory of CA19-9 as an Anchor Marker for Pancreatic Cancer Early DetectionJohannes F Fahrmann, C Max Schmidt, Xiangying Mao, et al.
The British Journal of Surgery|August 24, 2019
Validation of a nomogram to predict the risk of cancer in patients with intraductal papillary mucinous neoplasm and main duct dilatation of 10 mm or lessW Jung, T Park, Y Kim, et al.
Cell Reports. Medicine|September 20, 2023
A blood-based metabolomic signature predictive of risk for pancreatic cancerEhsan Irajizad, Ana Kenney, Tiffany Tang, et al.
Gut|December 20, 2023
Protein biomarkers and alternatively methylated cell-free DNA detect early stage pancreatic cancerRoni Ben-Ami, Qiao-Li Wang, Jinming Zhang, et al.
Biorxiv : the Preprint Server for Biology|December 18, 2023
Tumor-selective effects of active RAS inhibition in pancreatic ductal adenocarcinomaUrszula N Wasko, Jingjing Jiang, Alvaro Curiel-Garcia, et al.
Pageof 13